Weiss Multi-Strategy Advisers LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 118 filers reported holding RELMADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$570,000
+182.2%
30,000
+300.0%
0.02%
+240.0%
Q1 2022$202,000
-10.2%
7,500
+6.5%
0.01%0.0%
Q2 2021$225,000
-16.7%
7,043
-16.5%
0.01%0.0%
Q4 2020$270,000
-10.3%
8,434
+5.4%
0.01%
-37.5%
Q3 2020$301,000
-4.4%
8,000
-13.3%
0.01%
-33.3%
Q1 2020$315,000
-37.9%
9,225
-29.0%
0.01%
+50.0%
Q4 2019$507,00013,0000.01%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders